| Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: possible involvements of the L-arginine–NO pathway and opioid system A Ulugol, D Dokmeci, G Guray, N Sapolyo, F Ozyigit, M Tamer Life sciences 78 (14), 1592-1597, 2006 | 126 | 2006 |
| Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats A Ulugol, HC Karadag, M Tamer, Z Firat, A Aslantas, I Dokmeci Neuroscience letters 328 (2), 129-132, 2002 | 100 | 2002 |
| The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats A Ulugol, HC Karadag, Y Ipci, M Tamer, I Dokmeci Neuroscience letters 371 (2-3), 167-170, 2004 | 82 | 2004 |
| The endocannabinoid system as a potential therapeutic target for pain modulation A Ulugöl Balkan medical journal 2014 (2), 115-120, 2014 | 76 | 2014 |
| The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac A Ulugöl, F Özyigit, Ö Yesilyurt, A Dogrul Anesthesia & Analgesia 102 (2), 443-447, 2006 | 74 | 2006 |
| Systemic agmatine attenuates tactile allodynia in two experimental neuropathic pain models in rats HC Karadag, A Ulugol, M Tamer, Y Ipci, I Dokmeci Neuroscience letters 339 (1), 88-90, 2003 | 68 | 2003 |
| Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception A Dogrul, M Seyrek, B Yalcin, A Ulugol Progress in Neuro-Psychopharmacology and Biological Psychiatry 38 (1), 97-105, 2012 | 58 | 2012 |
| 5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice A Ulugol, C Oltulu, O Gunduz, C Citak, R Carrara, MR Shaqaqi, ... Pharmacology Biochemistry and Behavior 102 (2), 344-348, 2012 | 47 | 2012 |
| Anti-allodynic and anti-hyperalgesic effects of ceftriaxone in streptozocin-induced diabetic rats O Gunduz, C Oltulu, D Buldum, R Guven, A Ulugol Neuroscience letters 491 (1), 23-25, 2011 | 47 | 2011 |
| Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the beta-lactam antibiotic, ceftriaxone, in mice O Gunduz, C Oltulu, A Ulugol Pharmacology Biochemistry and Behavior 99 (1), 100-103, 2011 | 40 | 2011 |
| Involvement of descending serotonergic and noradrenergic systems and their spinal receptor subtypes in the antinociceptive effect of dipyrone A Gencer, O Gunduz, A Ulugol Drug research, 645-649, 2015 | 35 | 2015 |
| Combined systemic administration of morphine and magnesium sulfate attenuates pain-related behavior in mononeuropathic rats A Ulugol, A Aslantas, Y Ipci, A Tuncer, CH Karadag, I Dokmeci Brain research 943 (1), 101-104, 2002 | 35 | 2002 |
| The behavioral effects of MK-801 injected into nucleus accumbens and caudate-putamen of rats I Al-Khatib, HC Karadag, A Ulugöl Pharmacology Biochemistry and Behavior 52 (4), 723-730, 1995 | 32 | 1995 |
| Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice O Gunduz, HC Karadag, A Ulugol Pharmacology Biochemistry and Behavior 99 (4), 540-544, 2011 | 28 | 2011 |
| Lack of effect of ceftriaxone, a GLT-1 transporter activator, on spatial memory in mice I Karaman, G Kizilay-Ozfidan, CH Karadag, A Ulugol Pharmacology Biochemistry and Behavior 108, 61-65, 2013 | 27 | 2013 |
| Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase NC Tosun, O Gunduz, A Ulugol Journal of Neural Transmission 122, 363-367, 2015 | 25 | 2015 |
| Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212‐2, a cannabinoid receptor agonist KA Bilir, G Anli, E Ozkan, O Gunduz, A Ulugol Clinical and experimental dermatology 43 (5), 553-558, 2018 | 24 | 2018 |
| Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone P Elmas, A Ulugol Journal of Neural Transmission 120, 1533-1538, 2013 | 23 | 2013 |
| Comparison of the effects of tenoxicam and mid-laser irradiation on chronic adjuvant arthritis in rats. A Ulugöl, H Unalan, I Dökmeci, S Kokino Clinical and experimental rheumatology 15 (1), 83-86, 1997 | 23 | 1997 |
| THE EFFECT OF COMBINED SYSTEMIC ADMINISTRATION OF MORPHINE AND L-NAME, A NITRIC OXIDE SYNTHASE INHIBITOR, ON BEHAVIORAL SIGNS OF NEUROPATHIC PAIN IN RATS A Ulugol, A Aslantas, HC Karadag, ED Bulbul, A Tuncer, I Dokmeci Neuroscience Research Communications 30 (3), 143-153, 2002 | 22 | 2002 |
